GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Theraclion ALTHE.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.68

-3.14%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Theraclion

Its shares trade on Euronext Paris under the ticker ALTHE.PA. It has been listed since 25 April 2014. In the fiscal year to 31 December 2025, it reported revenue of €1.2m and a net loss of €5.7m. At that date it held total assets of €12.5m and shareholders' equity of −€2.6m.

Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
25 Apr 2014
Employees
25

Leadership

Pay as last reported

  • Mr. Yann DuchesneChairman of the Board€162,000
  • Mr. Martin DeterreChief Executive Officer€222,345
  • Mme. Lijuan DengDirector
  • Mr. Cedric BellangerIndependent Director€20,000
  • Mr. Mehdi El GlaouiIndependent Director€20,000
  • Dr. Ari KellenIndependent Director€20,000
  • Mr. Shawn LangerIndependent Director€20,000
  • Mr. Claude LenoirIndependent Director€10,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Theraclion SA possesses several strengths that contribute to its success in the market. These strengths include:

Weaknesses

  • Despite its strengths, Theraclion SA also faces certain weaknesses, which could hinder its growth and competitiveness. These weaknesses include:

Opportunities

  • Theraclion SA can capitalize on various opportunities available in the market to enhance its growth and profitability. These opportunities include:

Threats

  • Theraclion SA faces certain threats that could pose challenges to its business operations. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.